secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvation Bio Inc. (NUVB)
CIK:        0001811063
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0001193125-22-311807
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuvation Bio updates slide deck with clinical development timeline and milestones
--------------------------------------------------------------------------------

- Filed under Regulation FD; presentation available on company website.
- Updated clinical timeline and milestones shared for pipeline candidates.
- No specific financial or trial data disclosed in the 8-K filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811063/000119312522311807/0001193125-22-311807-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811063/000119312522311807/d433269d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-311807

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer